AU2012265231A1 - Nasal pharmaceutical formulation - Google Patents

Nasal pharmaceutical formulation

Info

Publication number: AU2012265231A1
Authority: AU; Australia
Prior art keywords: pharmaceutical formulation; nasal pharmaceutical; nasal; formulation; pharmaceutical
Prior art date: 2011-05-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2012265231A

Other versions

AU2012265231B2 (en

Inventor

Annegret Hildebrand-Cyrener

Joachim Maus

Ullrich Munzel

Hans Tritschler

Mario Weingart

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Meda Pharma GmbH and Co KG

Original Assignee

Meda Pharma GmbH and Co KG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-05-27

Filing date

2012-05-24

Publication date

2013-12-12

2011-05-27 Priority claimed from DE102011103347.9A external-priority patent/DE102011103347B4/en

2012-05-24 Application filed by Meda Pharma GmbH and Co KG filed Critical Meda Pharma GmbH and Co KG

2013-12-12 Publication of AU2012265231A1 publication Critical patent/AU2012265231A1/en

2016-09-08 Application granted granted Critical

2016-09-08 Publication of AU2012265231B2 publication Critical patent/AU2012265231B2/en

Status Ceased legal-status Critical Current

2032-05-24 Anticipated expiration legal-status Critical

Links

AU2012265231A 2011-05-27 2012-05-24 Nasal pharmaceutical formulation Ceased AU2012265231B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102011103347.9A DE102011103347B4 (en)	2011-05-27	2011-05-27	Nasal pharmaceutical formulation
DE102011103347.9		2011-05-27
PCT/EP2012/002222 WO2012163501A1 (en)	2011-05-27	2012-05-24	Nasal pharmaceutical formulation

Publications (2)

Publication Number	Publication Date
AU2012265231A1 true AU2012265231A1 (en)	2013-12-12
AU2012265231B2 AU2012265231B2 (en)	2016-09-08

Family

ID=46642459

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2012265231A Ceased AU2012265231B2 (en)	2011-05-27	2012-05-24	Nasal pharmaceutical formulation

Country Status (14)

Country	Link
US (1)	US20140194400A1 (en)
EP (1)	EP2714005A1 (en)
JP (1)	JP2014515360A (en)
CN (1)	CN103561721A (en)
AU (1)	AU2012265231B2 (en)
BR (1)	BR112013030260A2 (en)
CA (1)	CA2836025A1 (en)
DE (1)	DE102011103347B4 (en)
EA (1)	EA025203B1 (en)
GE (1)	GEP201606577B (en)
IL (1)	IL229497A0 (en)
MX (1)	MX2013013879A (en)
WO (1)	WO2012163501A1 (en)
ZA (1)	ZA201308905B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103893120A (en) *	2012-12-27	2014-07-02	重庆华邦制药有限公司	Fluticasone propionate spraying agent with improved stability
US11554229B2 (en)	2013-03-26	2023-01-17	OptiNose Inc.	Nasal administration
WO2014155192A2 (en) *	2013-03-26	2014-10-02	Optinose As	Nasal administration
RU2016152090A (en) *	2014-06-25	2018-07-27	Оптиноуз Ас	Intranasal introduction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6858596B2 (en) *	2000-08-05	2005-02-22	Smithkline Beecham Corporation	Formulation containing anti-inflammatory androstane derivative
EP1581245A2 (en) *	2002-12-17	2005-10-05	Nastech Pharmaceutical Company Inc.	Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
US9808471B2 (en) *	2003-04-16	2017-11-07	Mylan Specialty Lp	Nasal pharmaceutical formulations and methods of using the same
US20070178051A1 (en) *	2006-01-27	2007-08-02	Elan Pharma International, Ltd.	Sterilized nanoparticulate glucocorticosteroid formulations
JP2009526064A (en) *	2006-02-09	2009-07-16	シェーリングコーポレイション	Pharmaceutical formulation
AU2007257781B2 (en) *	2006-06-09	2012-11-22	Parion Sciences, Inc.	Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
JP2010195716A (en) *	2009-02-25	2010-09-09	Takeda Chem Ind Ltd	Nasal sleep-introducing drug
EP2437743A4 (en) *	2009-06-05	2012-11-28	Aciex Therapeutics Inc	Ophthalmic formulations of fluticasone and methods of use
AU2010324596A1 (en) *	2009-11-30	2012-06-14	Wisconsin Alumni Research Foundation	2-methylene-19,26-nor-(20S)-1alpha-hydroxyvitamin D3

2011
- 2011-05-27 DE DE102011103347.9A patent/DE102011103347B4/en not_active Expired - Fee Related
2012
- 2012-05-24 JP JP2014511774A patent/JP2014515360A/en active Pending
- 2012-05-24 BR BR112013030260A patent/BR112013030260A2/en not_active IP Right Cessation
- 2012-05-24 GE GEAP201213337A patent/GEP201606577B/en unknown
- 2012-05-24 CA CA2836025A patent/CA2836025A1/en not_active Abandoned
- 2012-05-24 US US14/122,561 patent/US20140194400A1/en not_active Abandoned
- 2012-05-24 MX MX2013013879A patent/MX2013013879A/en not_active Application Discontinuation
- 2012-05-24 WO PCT/EP2012/002222 patent/WO2012163501A1/en active Application Filing
- 2012-05-24 EA EA201391686A patent/EA025203B1/en not_active IP Right Cessation
- 2012-05-24 EP EP12745769.5A patent/EP2714005A1/en not_active Withdrawn
- 2012-05-24 CN CN201280024623.1A patent/CN103561721A/en active Pending
- 2012-05-24 AU AU2012265231A patent/AU2012265231B2/en not_active Ceased
2013
- 2013-11-19 IL IL229497A patent/IL229497A0/en unknown
- 2013-11-25 ZA ZA2013/08905A patent/ZA201308905B/en unknown

Publication	Publication Date	Title
EP3281664B8 (en)	2020-12-30	Nasal delivery devices
EP2706987B8 (en)	2015-05-27	Pharmaceutical compositions
HRP20181896T1 (en)	2019-02-22	Pharmaceutical formulations
EP2665503A4 (en)	2017-11-29	Medicament delivery device
GB2486567B (en)	2014-09-10	Pharmaceutical formulation
IL228465A0 (en)	2013-12-31	Pharmaceutical formulation comprising inositol
GB201105298D0 (en)	2011-05-11	Pharmaceutical preparation
AU2012265231A1 (en)	2013-12-12	Nasal pharmaceutical formulation
ZA201308905B (en)	2015-03-25	Nasal pharmaceutical formulation comprising fluticasone
HK1200342A1 (en)	2015-08-07	Nasal formulation
AU2011905393A0 (en)	2012-01-19	Pharmaceutical Composition
AU2011900419A0 (en)	2011-02-24	Cosmetic or pharmaceutical formulation
AU2011904970A0 (en)	2011-12-15	Pharmaceutical compositions
AU2011904699A0 (en)	2011-11-24	Pharmaceutical compositions
AU2011905442A0 (en)	2012-01-19	Formulation
AU2011905445A0 (en)	2012-01-19	Formulation
AU2012904295A0 (en)	2012-10-18	Pharmaceutical composition
AU2011904841A0 (en)	2011-12-08	Formulation
AU2011900931A0 (en)	2011-03-31	Pharmaceutical compositions and use thereof
GB201111577D0 (en)	2011-08-24	Pharmaceutical formulations
AU2012904962A0 (en)	2012-11-29	Pharmaceutical compositions
AU2011905421A0 (en)	2012-01-19	Ophthalmic Formulation